GET DAILY SIGNALSSS Innovations International (SSII) Q3 2026 Earnings Preview: Tracking Growth and Regulatory Progress
Key Takeaways
- SS Innovations International is expected to report its third-quarter 2026 results in early November, with analysts modeling revenue of roughly $15.1 million.
- Consensus estimates call for a net loss of about $0.01 per share, roughly in line with the prior quarter's results.
- Investor attention is likely to center on SSi Mantra installations, procedure volumes, and updates on the company's U.S. Food and Drug Administration (FDA) 510(k) submission.
- The company has delivered strong year-over-year revenue growth, but continues to operate at a net loss as it scales its surgical robotics platform.
- In its most recent quarter, revenue of $13.94 million came in roughly 16% above consensus, while earnings per share matched expectations.
- For more context on this ticker, explore its Major News, Today's Price Move, Price Targets, and Forecast pages.
- You can also discover automated trading ideas by exploring Trending AI Robots.
Why the Upcoming Report Matters
SS Innovations International (SSII) operates as a commercial-stage surgical robotics company, with its flagship SSi Mantra system positioned in a rapidly expanding yet capital-intensive medical technology sector. The third-quarter update provides a timely check on whether the firm can maintain its strong revenue momentum while addressing the losses associated with commercialization efforts, regulatory work, and international expansion. Following a record quarter in Q2 2026, the focus will be on whether growth in India and other markets holds steady. The release also coincides with ongoing work on the FDA 510(k) submission, which could serve as a meaningful step toward accessing the U.S. market.
What Analysts Expect for Q3 2026
Analyst consensus for the third quarter of 2026 points to revenue near $15.1 million and a net loss of roughly $0.01 per share. That revenue figure would mark a solid increase from the $12.83 million posted in the same quarter last year. For context, SS Innovations International (SSII) reported $13.94 million in revenue for Q2 2026, surpassing the approximately $12 million consensus by about 16%, while earnings per share of -$0.01 aligned with expectations. In Q1 2026, revenue reached about $11.1 million, more than doubling from the prior year. Since the company is not yet profitable, attention will likely stay on top-line expansion, gross margin trends, installation numbers, and any fresh details around regulatory milestones. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Market Sentiment Heading Into the Print
Investor mood ahead of the report reflects a notable pullback in the share price over the past year, even as longer-term optimism around the growth narrative persists. The stock has moved lower from its 52-week high, and lighter average trading volume could magnify any reaction around earnings. Key risks include ongoing cash burn, the need for additional funding flagged by management, and uncertainty over the timing of U.S. regulatory approval. Constructive updates on SSi Mantra adoption or the FDA process could support sentiment, whereas signs of slower installations or deeper losses might pressure the shares. From what I see, this setup makes the report particularly important to monitor closely.
Forward Signals Worth Watching
Looking past the headline figures, several areas stand out for investors. Installation and procedure volumes for the SSi Mantra system offer the most direct view of commercial progress, especially in India and other international markets. The FDA 510(k) process represents another key catalyst; the company recently responded to an agency request for additional information, so any further updates on timing could influence the outlook for U.S. market entry. Cost control and cash management will also draw scrutiny, as management has noted that current resources may not cover operations for the next twelve months. Finally, trends in gross margins and the geographic revenue breakdown will help assess whether top-line growth is translating into greater efficiency. I checked related patterns using Tickeron’s AI Pattern Search Engine to gauge how similar medical technology names have reacted in the past.
Exploring AI Tools for Deeper Analysis
I often turn to Tickeron’s AI Screener when preparing for earnings events like this one. It helps filter stocks by technical patterns, fundamentals, and AI-driven signals, which can surface useful context on how SS Innovations International (SSII) stacks up against peers without replacing traditional research. This kind of tool has become a regular part of my workflow for identifying comparable names and spotting potential breakout candidates ahead of key reports.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
SSII in -23.70% downward trend, falling for three consecutive days on November 10, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where SSII declined for three days, in 124 of 134 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for SSII turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 32 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.
The Aroon Indicator for SSII entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +11.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where SSII advanced for three days, in 62 of 95 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
SSII may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 56 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.846) is normal, around the industry mean (4.142). P/E Ratio (0.000) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (12.887) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 89 (best 1 - 100 worst), indicating slightly worse than average price growth. SSII’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 98 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SSII’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
If I Want to Establish a Self-Employed 401(k), Do I Have to Establish One for All Owners of My Business?
Can You Sell a Bond for Less Than the Price You Paid For It?
What is Capital Accumulation?
What Is the Volume-Weighted Average Price?
How Has Gold's Value Fluctuated Through History and What Does It Mean for Today's Investor?
General Information
Industry MedicalNursingServices
Advertisement